FIGURE 3.
Summary of efficacy outcome measures at 2 h in subgroup of triptan‐insufficient responders with insufficient efficacy. MBS, most bothersome migraine‐associated symptom
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.